Your trusted source

The first human trial testing a potential vaccine to prevent COVID-19 is “on track” with public distribution still projected in 12 to 18 months, which would be the “ultimate game changer” in the fight against the pandemic, White House health advisor Dr. Anthony Fauci said Wednesday, according to CNBC report.

The source reminds that U.S. health officials have been fast-tracking work with biotech company Moderna to develop a vaccine to prevent COVID-19. They began their first human trials on a potential vaccine March 16. Moderna Therapeutics' co-founder and director is American entrepreneur of Armenian descent Noubar Afeyan.

The trial had to test three different doses of the vaccine, Fauci said, adding that they’ve already tested the first two doses and are now administering the highest dose to human volunteers to see if there are any adverse reactions to it.

“It’ll take a few months to get the data to where we’ll feel confident to go to the phase two, and then a few months from now we’ll be in phase two and I think we’re right on target for the year to year and a half,” Fauci said at a White House press conference with President Donald Trump’s coronavirus task force.